Newfound genetic defect hints at clues for developing novel antimalarial agents.
Skolnick
A A
AA
D000962:Antimalarials; D015195:Drug Design; D004913:Erythrocytes, Abnormal / Q000502:physiology*; D006801:Humans; D007113:Immunity, Innate / Q000235:genetics; D008288:Malaria / Q000276:immunology
D000962:Antimalarials